FindTrial
Sign In

A Study of Combination Antithrombin and Thrombomodulin Therapy for Septic DIC -Systematic review and meta-analysis-

A Study of Combination Antithrombin and Thrombomodulin Therapy for Septic DIC-Systematic review and meta-analysis- - A Study of Combination Antithrombin and Thrombomodulin Therapy for Septic DIC-Systematic review and meta-analysis-

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000049820
Enrollment
Unknown
Registered
2022-12-31
Start date
2022-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

septic disseminated intravascular coagulation

Interventions

None listed

Sponsors

The Japanese Society on Thrombosis and Hamostasis
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with septic DIC. However, for RCTs that include sepsis in general or mixed DIC due to other underlying diseases such as trauma, leukemia, etc., if 1) the results of a subgroup analysis of "septic DIC" are presented in the main or separate paper, and 2) no significant background bias is introduced, the results will be adopted

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
28-day mortality—

Secondary

MeasureTime frame
hemorrhagic complications, DIC resolution rate—

Countries

Japan

Contacts

Public ContactTAKAAKI TOTOKI

kyusyu university Department of Anesthesiology & Critical Care Medicine

totoki.takaaki.645@m.kyushu-u.ac.jp092-641-1151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026